Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

Rhea-AI Summary

Aclaris Therapeutics, a clinical-stage biopharmaceutical firm focused on immuno-inflammatory diseases, announced that Dr. Neal Walker, President and CEO, will participate in a fireside chat at the Jefferies Healthcare Conference on June 8, 2022, at 11:30 a.m. ET in New York. The session will also allow for 1x1 meetings on the same day. A live webcast of the chat will be available on Aclaris’ website and archived for 30 days. The company is known for its innovative drug candidates aimed at addressing unmet patient needs in this therapeutic area.

WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. ET in New York, New York. Management will be available June 8th for 1x1 meetings.

A live webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

When will Aclaris Therapeutics participate in the Jefferies Healthcare Conference?

Aclaris Therapeutics will participate in the Jefferies Healthcare Conference on June 8, 2022.

Who is the CEO of Aclaris Therapeutics?

Dr. Neal Walker is the President and CEO of Aclaris Therapeutics.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics focuses on developing novel drug candidates for immuno-inflammatory diseases.

How can I access the webcast of Aclaris' fireside chat?

The webcast of Aclaris' fireside chat can be accessed through the 'Events' page of their website.

What date and time is the Aclaris fireside chat scheduled?

The Aclaris fireside chat is scheduled for June 8, 2022, at 11:30 a.m. ET.

Is the webcast of the fireside chat available after the event?

Yes, the webcast will be archived for at least 30 days on Aclaris' website.